Skip to main content
. Author manuscript; available in PMC: 2013 Apr 10.
Published in final edited form as: Clin Pharmacol Ther. 2011 Dec 21;91(2):257–263. doi: 10.1038/clpt.2011.221

Table 1.

study population characteristics

Controls Cases
N = 468 N = 225
Demographics
 Age (years) (± SD) 69 ± 12 67 ± 11
 Gender (% male) 62.8 64.9
 Race (%)
  European American 88 88.4
  African American 9.4 10.7
  Other 2.6 0.9
 Body mass index (kg/m2) (± SD) 30.2 ± 6.6 30.5 ± 6.0
Past medical history (%)
  Hypertension 84.6 72.9
  Diabetes 34.8 34.8
  Hyperlipidemia 95.5 87.1
Smoking
  Current 16.4 15.6
  Ever 47.1 38.7
  Never 36.4 45.8
 Heart failure 13.7 19.1
Primary event (%)
 MI 4.1 6.7
 Stent 67.9 70.2
 Both 28 23.1
Number of stents (%) N = 449 N = 210
  1 stent 65.2 56.6
  >1 stent 32.7 43.3
  Unknown 1.8 0.0
Stent type
  Bare metal 33.6 21.4
  Drug-eluting 60.8 67.1
  Mixed 2.9 3.3
  Unknown 2.7 8.1
Stent locationsa
  LMCA 1.1 3.3
  LAD 45.7 33.8
  LCX 22.0 25.7
  RCA 39.6 37.6
  Graft 2.4 15.7

LAD, left anterior descending coronary artery; LCX, left circumflex coronary artery; LMCA, left main coronary artery; MI, myocardial infarction; RCA, right coronary artery.

a

Percentages total more than 100% because patients may receive more than one intervention.